Clinical Trials · NCT03103009

Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia

CompletedPhase 1Octreotide (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
University of Colorado, Denver
Enrollment
1
Start date
Mar 2017
Locations
1 site, United States
Primary endpoint
Recording of Hypoglycemic events
View Octreotide compound reference